NIPC Law

Author The Judicial Office, UK Lic ence CC BYSA 4.0 Source Wikimedia Commons Jane Lambert Patents Court (Mr Justice Mellor) Neurim Pharmaceuticals (1991) Ltd and another v Generics UK Ltd (t/a Mylan) and another [2021] EWHC 2198 (Pat) (2 Aug 2021) This case shows how quickly the English courts can move to resolve disputes when there is a need for them do so.  On 2 Aug 2022 Mr Justice Mellor ordered a 2-day trial of a number of preliminary issues in a claim for the infringement of European patent (UK) 3 103 443  2 months after the application for the expedited trial  and 3 months after the patent had been granted. The reason for the urgency was that the patent prevented Mylan from marketing a treatment for insomnia through the use of melatonin. As Me Justice Mellor said at para [40] of his judgment in  Neurim Pharmaceuticals (1991) Ltd and another v Generics UK Ltd (t/a Mylan) and another [2021] EWHC 2198 (Pat) (2 Aug 2021): "i) Neurim has a prima facie valid pa...

Jane Lambert   Patents Court (Mr Justice Macaroli) Dr Reddy's Laboratories (UK) Ltd and others v Warner Lambert LLC and another [2021] EWHC 2182 (Ch) (30 July 2021) Each of the 35 claimants in these proceedings had been awarded an inquiry as to damages either for losses sustained as a result of an interim injunction that the defendants had agreed to pay or for losses resulting from threats of litigation that the court had held to be groundless.  Most of the claimants were pharmaceutical companies that supplied pregabalin  which they were allowed to distribute for the treatment of epilepsy and anxiety but not neuropathic pain.  The remaining claimants were the governments of the United Kingdom, Scotland, Wales and Northern Ireland and the National Health Service that wished to treat patients for neuropathic pain with generic products. The Dispute Warner Lambert Company LLC was the proprietor of  EP0641330 B1  for isobutylgaba, of which pregabalin is a deriv...